Denali Therapeutics Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Denali Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Denali Therapeutics Inc. for December 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 240,000 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 128,200 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 743,599 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 1,875,000 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Option Exercise | C | 0.00 | 14,499,999 | 0 | 0 | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | P | 18.00 | 275,000 | 4,950,000 | 19,462,499 | 19.2 M to 19.5 M (+1.43 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 240,000 | 0 | 1,111,799 | 871.8 K to 1.1 M (+27.53 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 128,200 | 0 | 871,799 | 743.6 K to 871.8 K (+17.24 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 743,599 | 0 | 743,599 | 0 to 743.6 K |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 1,875,000 | 0 | 19,187,499 | 17.3 M to 19.2 M (+10.83 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 2,500,000 | 0 | 17,312,499 | 14.8 M to 17.3 M (+16.88 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Buy | C | 0.00 | 14,499,999 | 0 | 14,812,499 | 312.5 K to 14.8 M (+4,640.00 %) |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 51 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 34 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 193 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 15,021 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 15,068 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 54,854 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 71,875 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 20 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 13 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 77 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 6,008 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 6,027 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 21,942 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 28,750 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 1,008 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 662 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 3,755 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 292,303 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 293,204 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 1,065,616 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Option Exercise | C | 0.00 | 1,397,326 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 51 | 0 | 1,379 | 1.3 K to 1.4 K (+3.84 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 20 | 0 | 1,328 | 1.3 K to 1.3 K (+1.53 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 1,008 | 0 | 1,308 | 300 to 1.3 K (+336.00 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 34 | 0 | 906 | 872 to 906 (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 13 | 0 | 872 | 859 to 872 (+1.51 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 662 | 0 | 859 | 197 to 859 (+336.04 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 193 | 0 | 5,146 | 5 K to 5.1 K (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 77 | 0 | 4,953 | 4.9 K to 5 K (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 3,755 | 0 | 4,876 | 1.1 K to 4.9 K (+334.97 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 15,021 | 0 | 400,456 | 385.4 K to 400.5 K (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 6,008 | 0 | 385,435 | 379.4 K to 385.4 K (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 292,303 | 0 | 379,427 | 87.1 K to 379.4 K (+335.50 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 15,068 | 0 | 401,692 | 386.6 K to 401.7 K (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 6,027 | 0 | 386,624 | 380.6 K to 386.6 K (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 293,204 | 0 | 380,597 | 87.4 K to 380.6 K (+335.50 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 54,854 | 0 | 1,460,570 | 1.4 M to 1.5 M (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 21,942 | 0 | 1,405,716 | 1.4 M to 1.4 M (+1.59 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 1,065,616 | 0 | 1,383,774 | 318.2 K to 1.4 M (+334.93 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 71,875 | 0 | 1,914,833 | 1.8 M to 1.9 M (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 28,750 | 0 | 1,842,958 | 1.8 M to 1.8 M (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FIL Ltd | Buy | C | 0.00 | 1,397,326 | 0 | 1,814,208 | 416.9 K to 1.8 M (+335.19 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 1,246 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 41,561 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 112,590 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 498 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 16,624 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 45,035 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 24,240 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 808,013 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Option Exercise | C | 0.00 | 2,188,869 | 0 | 0 | ||
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 1,246 | 0 | 33,215 | 32 K to 33.2 K (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 498 | 0 | 31,969 | 31.5 K to 32 K (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 24,240 | 0 | 31,471 | 7.2 K to 31.5 K (+335.22 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 41,561 | 0 | 1,107,257 | 1.1 M to 1.1 M (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 16,624 | 0 | 1,065,696 | 1 M to 1.1 M (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 808,013 | 0 | 1,049,072 | 241.1 K to 1 M (+335.19 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 112,590 | 0 | 2,999,521 | 2.9 M to 3 M (+3.90 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 45,035 | 0 | 2,886,931 | 2.8 M to 2.9 M (+1.58 %) | |
| Dec 14 2017 | DNLI | Denali Therapeutic ... | FMR LLC | Buy | C | 0.00 | 2,188,869 | 0 | 2,841,896 | 653 K to 2.8 M (+335.19 %) | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Flagship Ventures Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 156,250 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Flagship Ventures Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 125,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Flagship Ventures Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,324,999 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Flagship Ventures Fund V, L.P. | 10% Owner | Buy | C | 0.00 | 8,606,249 | 0 | 8,918,749 | 312.5 K to 8.9 M (+2,754.00 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 312,500 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 375,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 10,068,749 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 10,756,249 | 0 | 11,068,749 | 312.5 K to 11.1 M (+3,442.00 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Buy | C | 0.00 | 25,000 | 0 | 3,139,043 | 3.1 M to 3.1 M (+0.80 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 19,774 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 105,225 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 19,774 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 105,225 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 19,774 | 0 | 19,774 | 0 to 19.8 K |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 105,225 | 0 | 105,225 | 0 to 105.2 K |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 19,774 | 0 | 19,774 | 0 to 19.8 K |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 105,225 | 0 | 105,225 | 0 to 105.2 K |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Option Exercise | C | 0.00 | 62,500 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Buy | C | 0.00 | 62,500 | 0 | 137,500 | 75 K to 137.5 K (+83.33 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 312,500 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 375,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 10,068,749 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,756,249 | 0 | 11,068,749 | 312.5 K to 11.1 M (+3,442.00 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Buy | C | 0.00 | 250,000 | 0 | 250,000 | 0 to 250 K |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | C | 0.00 | 500,000 | 0 | 1,000,000 | 500 K to 1000 K (+100.00 %) |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | C | 0.00 | 12,500 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Buy | C | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
| Dec 08 2017 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 |